Clinical Trial Update: Trial of Adjunctive Vitamin D in Tuberculosis Treatment [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating adjunctive Vitamin D (cholecalciferol) in the treatment of pulmonary tuberculosis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pulmonary Tuberculosis

Drugs mentioned

• Cholecalciferol (Vitamin D3) (cholecalciferol)

Snippet

Sponsor: Barts & The London NHS Trust | Conditions: Tuberculosis, Pulmonary | Phase 3 | Status: COMPLETED